BIOQuébec, BioNJ, and Choose New Jersey announce a Memorandum of Understanding (MOU) that aims to enhance cooperation and collaboration between the life sciences sectors in Québec and New Jersey, signed during Choose New Jersey’s Governor-led economic mission in Canada. The strategic partnership is expected to create opportunities for members of both organizations to access new resources, connect with international markets, and participate in events designed to drive innovation and growth in the biopharma and biotech industries.
“New Jersey is the home of innovation with a thriving life sciences sector reaching new heights through collaboration with industry partners abroad,” said Gov. Phil Murphy. “The partnership between BIOQuébec and BioNJ is a step forward in delivering crucial results to advance research and development, education, and overall growth by fighting for patients’ interests in New Jersey and beyond.”
The MOU provides a framework for cooperation that includes the sharing of best practices, the promotion of bilateral events such as trade missions, and participation in joint conferences. This collaboration will enable the life sciences communities in both regions to expand their reach and impact on a global scale.
This partnership marks a significant commitment by both organizations to advance their respective sectors while creating real-world opportunities for their members. Further details on the specific events and opportunities arising from the partnership will be shared with members in the coming months.
BIOQuébec’s CEO, Benoit Larose, stated, “We are excited to partner with BioNJ through this Memorandum of Understanding. In the current global context, where the life sciences industry faces both unprecedented challenges and opportunities, it is crucial for trade associations like ours to nurture strong relationships with international partners. Such collaborations not only mitigate the risks associated with volatile supply chains for industry but also create opportunities to generate value for our members. This partnership will enrich the biotech sectors in both Québec and New Jersey through shared knowledge and initiatives, and it represents a concrete step towards expanding our industries’ influence abroad.”
“Across Québec, the United States, and especially here in New Jersey, numerous companies have forged longstanding and well-established strategic partnerships,” remarked Debbie Hart, president & CEO of BioNJ. “Alliances, like the one between BioNJ and BIOQuébec, serve as catalysts for innovation, sparking new business ventures and fostering cutting-edge research collaborations. We are eager to bring our members together in a shared mission to elevate the life sciences sector, with the ultimate aim of accelerating the delivery of transformative medical breakthroughs to patients across the globe.”
“As New Jersey’s leading business attraction organization, Choose New Jersey is proud to facilitate this powerful collaboration to bring together New Jersey and Quebec’s formidable life sciences sectors to bolster both economies,” said Wesley Mathews, President & CEO of Choose New Jersey. “This agreement creates pathways for New Jersey’s biopharma and biotech companies to scale not only their businesses, but ideas, across the globe.”
To view the full MOU, click here.
To access more business news, visit NJB News Now.
Related Articles: